2020, Number 2
<< Back
Rev Mex Urol 2020; 80 (2)
Confounding bias in the association between marijuana use and testicular germ cell tumors
García-Perdomo HA, Dávila-Raigoza AM
Language: English
References: 7
Page: 1-2
PDF size: 93.04 Kb.
Text Extraction
Dear Editor
Regarding the manuscript written by Ghasemiesfe et al. “Association
Between Marijuana Use and Risk of Cancer: A systematic review and
meta-analysis” and published in the JAMA Network Open journal, we
would like to make some comments.
1. First, the original idea was to submit this letter to the JAMA Network
Open journal but, interestingly, they do not publish letters to the editor.
At any rate, the article has some critical flaws regarding the supposed
association that need to be carefully analyzed, as readers will see.
REFERENCES
Ghasemiesfe M, Barrow B, Leonard S, Keyhani S, Korenstein D. Association Between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open. 2019;2(11): e1916318. doi: 10.1001/ jamanetworkopen.2019.16318
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. John Wiley & Sons; 2011. 659 p.
García-Perdomo HA. Evidence synthesis and meta-analysis: a practical approach. Int J Urol Nurs. 2016;10(1):30–6. doi: 10.1111/ijun.12087
Richiardi L, Pettersson A, Akre O. Genetic and environmental risk factors for testicular cancer. Int J Androl. 2007;30(4):230–40; discussion 240- 241. doi: 10.1111/j.1365-2605.2007.00760.x
Laguna MP, Wondergem N, Wink MH, Wijkstra H, Rosette J de la. Avances en el diagnostico ecográfico del cáncer de próstata. Arch Esp Urol. 2006;59(10):965–76.
Wang YK, Bashashati A, Anglesio MS, Cochrane DR, Grewal DS, Ha G, et al. Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes. Nat Genet. 2017;49(6):856–65. doi: 10.1038/ ng.3849
Loveday C, Litchfield K, Levy M, Holroyd A, Broderick P, Kote-Jarai Z, et al. Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer. Oncotarget. 2018;9(16):12630–8. doi: 10.18632/oncotarget.23117